India, Oct. 20 -- Alpha Teknova (TKNO) on Tuesday said it priced an underwritten public offering of 8 million common shares at $5 each, with expected gross proceeds of $40 million before underwriting discounts, commissions and offering expenses.
The reagent manufacturer granted underwriters a 30-day option to purchase up to 1.2 million additional shares. All shares are being sold by Teknova.
The offering is expected to close on or about October 22, 2026, subject to customary closing conditions.
Teknova plans to use net proceeds for general corporate purposes, potentially including repayment of outstanding debt.
The company said it may use a portion of the net proceed to acquire or invest in complementary businesses, products or technolo...